###### Strengths and limitations of this study

-   There is a large sample for analysis.

-   The hand grip strength and ocular parameters measured were standardised.

-   The cross-sectional design of the study prevents dynamic analysis.

-   Only Chinese in urban area were included.

-   The findings may not generalise to types 1 diabetes mellitus and patients with diabetic retinopathy.

Introduction {#s1}
============

Diabetes has become a growing health problem, which can cause cardiovascular diseases and death.[@R1] Diabetic retinopathy (DR) may lead to severe visual disorders. It was estimated that diabetes affected 415 million adults in 2015 and will affect 642 million people in 2040.[@R2] Among the patients with diabetes, 34.6% had DR, accounting for 2.6% of all blindness.[@R3] At present, optical coherence tomography (OCT) examinations used in clinics provide an accurate reflection of fundus changes, but widespread performance of this approach is expensive and inconvenient.

Grip strength is an indicator of upper limb muscle function and tension, and it is one of the important indicators of ageing in the human population.[@R5] Hand grip strength (HGS) is easy to measure and has great clinical significance. It was well documented that low grip strength was related to higher risk of type 2 diabetes.[@R6] Furthermore, reduced grip strength was independent predictor of pre-diabetes in Chinese adults.[@R8] Fukuda *et al* [@R9] reported that lower muscle quality was related with higher odds of DR in patients with diabetes. Evidence has suggested that the size of a patients' retinal artery is independently related to grip strength in elderly patients living in Scotland.[@R10] The Beaver Dam Eye Study indicated that men with increased HGS had lower odds of early and later age-related macular degeneration by 28% and 55%, respectively.[@R11]

The retina and choroid are important layers in the eyeball, and retinal thickness (RT) and choroidal thickness (CT) are both useful indicators of overall eye health.[@R12] The choroid provides the retinal pigment epithelium with metabolic support and nourishes the optic nerve, choroid and outer retina. The normality of choroidal structure and function plays a key role in the function of the retina.[@R13] Abnormalities of RT and CT have been involved in the pathogenesis of DR. The choroid in patients with diabetes but without DR is thinner than that in healthy people but thicker than that in patients with DR.[@R14] Thinning of the choroid is considered to be an early sign of diabetes in patients with no clinical DR.[@R15] To the best of our knowledge, the potential associations of grip strength with RT or CT have not been explored in previous studies. Therefore, to address this important consideration, the objective of this study was to evaluate the associations of grip strength with RT and CT in patients with diabetes using swept-source optical coherence tomography (SS-OCT).

Methods {#s2}
=======

Subjects {#s2-1}
--------

This is a cross-sectional study, which was conducted at the Zhongshan Ophthalmic Center (ZOC), affiliated to Sun Yat-sen University, China. The study was performed in accordance with the tenets of the Helsinki Declaration. Informed consent form was obtained from all subjects before entering.

Eligible subjects included ocular treatment-naive patients with type 2 diabetes between the ages of 30 and 80 years. Participants were excluded if they had any of the following conditions: evidence of DR based on ETDRS 7 photography, an axial length (AL) \>30 mm, a spherical equivalent \> −10 D, a cylinder degree ≥3.0 D, anisometropia of ≥2.0 D, a C/D ratio ≥0.5 or inter-eye asymmetry ≥0.2, a history of ocular disease (except for light cataract) or trauma, a history of ocular laser or surgical interventions and/or a history of systemic diseases such as stroke, chronic kidney disease, cancer or chronic obstructive pulmonary disease, history of diabetic polyneuropathy.[@R16]

Systemic measurements {#s2-2}
---------------------

Standardised questionnaires were used to obtain the information of age, sex, length of time patient has had diabetes, medication compliance, presence of other systematic chronic diseases and risk factors. Standardised protocols were followed to measure the systolic blood pressure (SBP), diastolic blood pressure (DBP), height and weight. Blood and urine samples were obtained from all patients, and they were analysed for the following parameters: serum creatinine, microalbuminuria, haemoglobin A1c (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol. The most frequently studied tag single nucleotide polymorphisms (rs2228570) of vitamin D receptor was genotyped using TaqMan assays.

Hand grip strength {#s2-3}
------------------

HGS is a proxy of muscle mass and strength. A commercial dynamometer (Yuejian WL-1000, Nantong, China) was used to measure HGS twice for each hand according to standardised protocol. HGS was obtained in a standing position, except for those with physical limitations. Participants' shoulders were retracted and rotated, elbows were bent 90 degrees, and forearms and wrists were in a horizontal position. The dominant or non-dominant hand was randomly adopted to test first by squeezing the dynamometer handle as hard as possible for a few seconds and then repeat the test with the other hand. Each hand is tested twice, and the two tests are alternated. The average value of the four tests was used for statistical analysis. Subjects who had undergone hand surgery or had severe hand pain or wrist arthritis in the past 6 months were excluded.

Ocular examination {#s2-4}
------------------

Comprehensive ocular examinations were conducted for all participants, including slit-lamp biomicroscopy, ophthalmoscopy, visual acuity and intraocular pressure. The optical low-coherence reflectometry (Lenstar LS900; Haag-Streit AG, Koeniz, Switzerland) was used to measure the AL, anterior chamber depth and lens thickness. The autorefractor (KR8800; Topcon, Tokyo, Japan) was used to measure refraction after pupil dilation. The digital fundus camera (Canon CR-2, Tokyo, Japan) was used to obtain standardised retinal images in ETDRS 7 fields after pupil dilation. DR was diagnosed using International Clinical Diabetic Retinopathy and Diabetic Macular Oedema Disease Severity Scales.

SS-OCT imaging {#s2-5}
--------------

The retinal and choroidal images were obtained by using a commercial SS-OCT device (DRI OCT-2 Triton; Topcon), which has the speed of 100 000 A-scans/s and axial resolution of 8 µm. The imaging method has been described elsewhere in detail.[@R17] The 7×7 mm raster scan protocol was used to obtain 3-D images centring on the macula; the RT and CT in ETDRS 9 sectors were calculated automatically by the built-in software. The ETDRS sector divides the macular into two rings, including the inner and outer rings, which were 1--3 mm and 3--6 mm, respectively ([figure 1](#F1){ref-type="fig"}). In addition, the average RT and CT in all nine grids were calculated. An experienced technician performed all the OCT scans. All participants confirmed that they had not taken caffeine, alcohol and medications ≥24 hours before OCT imaging. The images with any evidence of any of the following conditions were excluded: image quality index ≤50, eye movement, artefacts, segmentation failure.

![Illustration of measurements of retinal and choroidal thickness in Early Treatment Diabetic Retinopathy Study 9 sectors using swept-source optical coherence tomography. (A) Retinal thickness; (B) choroidal thickness.](bmjopen-2020-036782f01){#F1}

Statistical analyses {#s2-6}
--------------------

According to the scores of grip strength from low to high, the participants were divided into four groups: Q1, Q2, Q3 and Q4. The Kolmogorov--Smirnov test was used to confirm the normal distribution. The Fisher exact test was used for categorical variables. The analysis of variance test was used to evaluate the intergroup difference of demographic, systemic and ocular parameters. Bivariate scatter plots were created to display the potential factors affecting RT and CT. Linear regression analyses were used to assess the association of RT and CT with demographic or ocular parameters, such as age, sex, AL, HbA1c and other parameters previously mentioned.[@R17] Univariate analysis showed that the predictive variables were significant, which were then entered into the final multivariate equation. The statistical significance cut-off was set at 0.05. All analyses were conducted using Stata V.14.0 software (Stata Corporation).

Results {#s3}
=======

A total of 1029 patients without any evidence of DR were included in the present study, which included 616 (59.86%) women with an average age of 64.5±7.7 years. [Table 1](#T1){ref-type="table"} presents the features of the participants. Differences in gender, age, height, weight, TC, serum creatinine, HDL-C, CCT and AL between each group were found to be statistically significant (p\<0.05).

###### 

Demographic and clinical characteristics of patients with diabetes without retinopathy

  Characteristics                   All           Quarter of grip strength   P value                                  
  --------------------------------- ------------- -------------------------- ------------- ------------- ------------ -------------
  No of subjects                    1029          258                        260           255           256          --
  Female, n (%)                     616 (59.86)   224 (86.82)                215 (82.69)   129 (50.59)   48 (18.75)   **\<0.001**
  Use of insulin, n (%)             163 (16.03)   40 (15.69)                 39 (15.18)    39 (15.42)    45 (17.86)   0.836
  Age, years                        64.5±7.7      66.2±7.2                   64.7±7.4      63.6±7.8      63.6±8.1     **\<0.001**
  Duration of diabetes, years       8.1±6.6       8.7±6.7                    8.3±6.7       7.5±6.3       8.1±6.6      0.214
  HbA1c, %                          6.8±1.3       6.8±1.2                    6.7±1.3       6.8±1.3       6.9±1.4      0.507
  Height, cm                        160.1±8.1     155.4±6.9                  157.8±6.7     161.7±6.9     165.5±8.0    **\<0.001**
  Weight, kg                        63.7±11.5     59.5±9.9                   60.7±9.9      65.0±10.0     69.7±13.0    **\<0.001**
  Systolic blood pressure, mm Hg    133.7±18.5    132.6±19.2                 134.3±18.4    134.1±18.2    133.9±18.1   0.714
  Diastolic blood pressure, mm Hg   70.7±10.4     69.6±10.8                  70.3±9.9      71.4±10.0     71.4±10.9    0.112
  Total cholesterol, mmol/L         4.8±1.0       4.9±1.0                    5.0±1.1       4.8±1.0       4.6±1.0      **0.001**
  Serum creatinine, μmol/L          70.3±19.3     68.0±20.2                  65.2±19.8     71.3±18.3     76.6±17.0    **\<0.001**
  HDL-C, mmol/L                     1.3±0.4       1.4±0.4                    1.4±0.4       1.3±0.4       1.2±0.4      **\<0.001**
  LDL-C, mmol/L                     3.1±0.9       3.1±0.9                    3.2±1.0       3.1±0.9       3.0±0.9      0.122
  Triglycerides, mmol/L             2.3±1.6       2.4±1.6                    2.3±1.5       2.3±1.7       2.3±1.7      0.976
  C reactive protein, mg/L          2.7±7.4       2.8±3.5                    3.1±12.3      2.4±3.8       2.4±6.5      0.658
  Microalbuminuria, mg/mL           4.1±14.9      4.7±14.7                   4.9±23.0      3.3±8.0       3.6±9.0      0.530
  BCVA, logMAR                      0.2±0.1       0.2±0.1                    0.2±0.1       0.2±0.2       0.2±0.1      0.133
  Intraocular pressure, mm Hg       16.2±2.7      16.4±2.8                   16.2±2.6      15.9±2.7      16.1±2.8     0.278
  Central corneal thickness, μm     546.1±31.5    545.8±29.6                 544.8±30.8    542.8±33.1    550.9±31.9   **0.026**
  Axial length, mm                  23.6±1.1      23.4±1.0                   23.5±1.2      23.6±1.1      23.8±1.0     **\<0.001**

Bold indicates statistically significant.

BCVA, best-corrected visual acuity; HbA1c, haemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.

[Table 2](#T2){ref-type="table"} presents the distribution of RT and CT in each sector across groups. The RT and CT differed significantly among the four groups (p\<0.001, RT in the outer inferior p=0.0483). Both RT and CT decreased in the lower quartile of HGS ([figure 2](#F2){ref-type="fig"}).

![Boxplots showing the distribution of retinal thickness (RT) and choroidal thickness stratified by quartiles of the hand grip strength. (A) Average RT versus grip strength; (B) RT in central field versus grip strength; (C) average choroidal thickness versus grip strength; (D) choroidal thickness in central field versus grip strength. MCT, mean choroidal thickness.](bmjopen-2020-036782f02){#F2}

###### 

Differences in retinal and choroidal thickness among groups by quartiles of grips strength

  Parameters            All          Quartile 1   Quartile 2   Quartile 3   Quartile 4   P value
  --------------------- ------------ ------------ ------------ ------------ ------------ -------------
  Retinal thickness                                                                      
   Outer superior, μm   265.8±18.9   261.8±15.6   265.9±20.0   266.6±22.7   268.8±15.9   **\<0.001**
   Inner superior, μm   301.5±18.3   296.6±15.1   301.3±19.1   302.3±19.7   305.9±18.1   **\<0.001**
   Outer temporal, μm   251.5±16.9   247.4±15.1   250.5±18.2   252.6±17.1   255.5±15.8   **\<0.001**
   Inner temporal, μm   288.8±17.7   284.4±15.8   286.8±17.2   290.2±18.8   294.0±17.6   **\<0.001**
   Central field, μm    228.4±23.5   222.5±19.1   225.6±22.0   231.6±25.7   234.2±25.0   **\<0.001**
   Inner nasal, μm      300.9±18.4   296.4±16.1   299.6±18.9   301.9±18.5   305.6±18.8   **\<0.001**
   Outer nasal, μm      280.0±17.9   276.3±15.8   279.2±18.7   280.6±18.6   284.0±17.6   **\<0.001**
   Inner inferior, μm   297.2±19.6   292.8±17.2   295.8±20.5   297.9±19.7   302.5±19.8   **\<0.001**
   Outer inferior, μm   255.8±19.0   253.1±15.1   255.7±24.3   256.6±18.1   257.6±17.0   **0.0483**
   Average, μm          274.4±15.3   270.2±12.9   273.4±15.6   275.6±16.1   278.7±15.1   **\<0.001**
  Choroidal thickness                                                                    
   Outer superior, μm   192.5±75.1   178.2±74.2   188.9±74.1   193.7±74.0   209.4±75.3   **\<0.001**
   Inner superior, μm   202.0±81.5   187.2±81.1   200.2±79.5   201.1±82.1   219.7±80.2   **\<0.001**
   Outer temporal, μm   173.9±65.0   159.1±59.6   177.0±62.8   170.6±67.9   189.0±66.2   **\<0.001**
   Inner temporal, μm   195.4±74.4   179.3±69.1   199.1±72.5   191.1±77.3   212.3±74.9   **\<0.001**
   Central field, μm    201.9±83.8   184.9±80.4   202.6±83.2   199.1±85.8   221.0±82.4   **\<0.001**
   Inner nasal, μm      189.6±85.5   171.4±81.0   190.6±85.0   189.5±86.5   207.2±86.1   **\<0.001**
   Outer nasal, μm      149.9±79.5   132.9±72.0   151.5±80.4   153.3±81.5   162.0±81.4   **\<0.001**
   Inner inferior, μm   188.2±83.5   166.4±77.2   190.5±83.6   187.6±83.4   208.6±84.7   **\<0.001**
   Outer inferior, μm   167.0±78.1   147.0±70.2   169.1±78.5   166.8±79.3   185.3±79.7   **\<0.001**
   Average, μm          184.5±73.6   167.4±69.1   185.5±72.9   183.6±74.8   201.6±73.8   **\<0.001**

Bold indicates statistically significant.

[Table 3](#T3){ref-type="table"} presents the association between HGS and RT based on multivariable regression analyses. After adjusting for age and gender, the average RT and CT decreased by 0.14 µm (p=0.011) and 0.57 µm (p=0.037), respectively, for 1 kg of reduced HGS. There was a statistically significant association between HGS and RT in at least one group in each region except the outer inferior. After adjusting for age, sex, AL, HbA1c, duration of diabetes, insulin usage, height, weight and SBP and DBP, the average RT and CT decreased by 0.13 µm (p=0.024) and 0.65 µm (p=0.013), respectively, for 1 kg of reduced HGS. The HGS was significantly related to RT in at least one group in each region except the outer inferior, the inner inferior, nasal and temporal. There was a statistically significant correlation between HGS and CT in at least one group in each region, except in the outer superior region ([table 4](#T4){ref-type="table"}).

###### 

Association of grip strength and retinal thickness by multivariate linear regression analyses

  Retinal thickness    Model 1\*    Model 2†                                                      
  -------------------- ------------ ----------------- ----------- ------------ ------------------ -----------
  Average, μm                                                                                     
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          2.16         (−0.28 to 4.61)   0.083       1.71         (−0.75 to 4.168)   0.174
   Quantile 3          2.10         (−0.48 to 4.69)   0.111       1.33         (−1.28 to 3.935)   0.319
   Quantile 4          3.68         (0.81 to 6.55)    **0.012**   3.35         (0.44 to 6.256)    **0.024**
   Per 1 kg increase   0.14         (0.03 to 0.25)    **0.011**   0.13         (0.02 to 0.24)     **0.024**
  Central field, μm                                                                               
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          2.50         (−1.42 to 6.43)   0.211       1.90         (−2.04 to 5.831)   0.345
   Quantile 3          5.08         (0.92 to 9.24)    **0.017**   4.62         (0.45 to 8.790)    **0.030**
   Quantile 4          4.53         (−0.08 to 9.13)   0.054       4.15         (−0.49 to 8.801)   0.080
   Per 1 kg increase   0.16         (−0.02 to 0.33)   0.082       0.15         (−0.03 to 0.32)    0.109
  Outer superior, μm                                                                              
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          3.03         (−0.08 to 6.14)   0.056       2.65         (−0.43 to 5.725)   0.091
   Quantile 3          2.49         (−0.80 to 5.78)   0.138       1.47         (−1.79 to 4.734)   0.375
   Quantile 4          4.44         (0.80 to 8.08)    **0.017**   3.74         (0.11 to 7.373)    **0.043**
   Per 1 kg increase   0.19         (0.05 to 0.33)    **0.008**   0.16         (0.02 to 0.30)     **0.022**
  Outer inferior, μm                                                                              
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          1.49         (−1.65 to 4.62)   0.352       1.27         (−1.83 to 4.373)   0.420
   Quantile 3          1.17         (−2.15 to 4.49)   0.489       0.49         (−2.79 to 3.778)   0.768
   Quantile 4          1.86         (−1.82 to 5.53)   0.321       1.90         (−1.76 to 5.561)   0.308
   Per 1 kg increase   0.06         (−0.08 to 0.21)   0.368       0.06         (−0.08 to 0.20)    0.377
  Outer nasal, μm                                                                                 
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          1.72         (−1.16 to 4.60)   0.243       1.63         (−1.20 to 4.475)   0.259
   Quantile 3          1.16         (−1.89 to 4.21)   0.457       0.55         (−2.46 to 3.557)   0.721
   Quantile 4          3.64         (0.26 to 7.02)    **0.035**   3.46         (0.11 to 6.810)    **0.043**
   Per 1 kg increase   0.14         (0.01 to 0.27)    **0.031**   0.14         (0.01 to 0.26)     **0.040**
  Outer temporal, μm                                                                              
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          1.94         (−0.78 to 4.66)   0.162       1.83         (−0.80 to 4.449)   0.172
   Quantile 3          1.88         (−1.01 to 4.76)   0.202       1.02         (−1.76 to 3.799)   0.472
   Quantile 4          3.36         (0.17 to 6.56)    **0.039**   2.72         (−0.37 to 5.818)   0.085
   Per 1 kg increase   0.14         (0.02 to 0.27)    **0.022**   0.12         (0.00 to 0.24)     0.053
  Inner superior, μm                                                                              
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          3.62         (0.61 to 6.63)    **0.018**   3.18         (0.13 to 6.226)    **0.041**
   Quantile 3          2.39         (−0.80 to 5.58)   0.142       1.68         (−1.54 to 4.912)   0.306
   Quantile 4          4.52         (0.99 to 8.05)    **0.012**   4.46         (0.86 to 8.053)    **0.015**
   Per 1 kg increase   0.15         (0.01 to 0.29)    **0.032**   0.14         (0.00 to 0.28)     **0.046**
  Inner inferior, μm                                                                              
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          1.73         (−1.47 to 4.94)   0.289       0.88         (−2.29 to 4.059)   0.586
   Quantile 3          1.01         (−2.39 to 4.40)   0.561       0.01         (−3.36 to 3.377)   0.995
   Quantile 4          3.51         (−0.25 to 7.27)   0.067       3.38         (−0.37 to 7.133)   0.077
   Per 1 kg increase   0.15         (0.00 to 0.29)    **0.048**   0.13         (−0.01 to 0.28)    0.069
  Inner nasal, μm                                                                                 
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          2.15         (−0.89 to 5.18)   0.165       1.40         (−1.67 to 4.473)   0.372
   Quantile 3          2.02         (−1.19 to 5.24)   0.217       1.25         (−2.00 to 4.509)   0.451
   Quantile 4          3.86         (0.30 to 7.42)    **0.034**   3.50         (−0.13 to 7.124)   0.059
   Per 1 kg increase   0.15         (0.01 to 0.28)    **0.038**   0.13         (−0.01 to 0.27)    0.067
  Inner temporal, μm                                                                              
   Quantile 1          1.00 (Ref)                                 1.00 (Ref)                      
   Quantile 2          1.34         (−1.55 to 4.23)   0.363       0.66         (−2.27 to 3.577)   0.660
   Quantile 3          1.82         (−1.24 to 4.88)   0.243       0.91         (−2.18 to 4.008)   0.563
   Quantile 4          3.40         (0.02 to 6.79)    **0.049**   2.84         (−0.61 to 6.287)   0.106
   Per 1 kg increase   0.15         (0.02 to 0.28)    **0.021**   0.13         (0.00 to 0.26)     0.055

Bold indicates statistically significant.

\*Model 1: adjusted for age and sex.

†Model 2: adjusted for age, gender, axial length, haemoglobin A1c, diabetes duration, use of insulin, height, weight, systolic blood pressure and diastolic blood pressure.

###### 

Association of grip strength and choroidal thickness by multivariate linear regression analyses

  Choroidal thickness   Model 1\*   Model 2†                                                    
  --------------------- ----------- ------------------- ----------- ------- ------------------- -----------
  Average, μm                                                                                   
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           13.37       (1.43 to 25.31)     **0.028**   13.51   (2.26 to 24.75)     **0.019**
   Quantile 3           3.66        (−8.98 to 16.31)    0.570       1.66    (−10.26 to 13.58)   0.784
   Quantile 4           17.52       (3.52 to 31.51)     **0.014**   20.42   (7.14 to 33.69)     **0.003**
   Per 1 kg increase    0.57        (0.03 to 1.11)      **0.037**   0.65    (0.13 to 1.16)      **0.013**
  Central field, μm                                                                             
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           13.00       (−0.82 to 26.83)    0.065       13.47   (0.50 to 26.45)     **0.042**
   Quantile 3           1.02        (−13.63 to 15.66)   0.892       −1.39   (−15.14 to 12.35)   0.842
   Quantile 4           18.06       (1.85 to 34.27)     **0.029**   21.39   (6.08 to 36.70)     **0.006**
   Per 1 kg increase    0.57        (−0.05 to 1.20)     0.072       0.65    (0.06 to 1.24)      **0.031**
  Outer superior, μm                                                                            
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           5.65        (−6.56 to 17.87)    0.364       5.01    (−6.78 to 16.80)    0.405
   Quantile 3           0.89        (−12.05 to 13.83)   0.893       −1.34   (−13.84 to 11.15)   0.833
   Quantile 4           10.78       (−3.54 to 25.11)    0.140       13.60   (−0.32 to 27.51)    0.055
   Per 1 kg increase    0.39        (−0.16 to 0.94)     0.167       0.47    (−0.07 to 1.00)     0.088
  Outer inferior, μm                                                                            
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           16.85       (4.29 to 29.40)     **0.009**   16.59   (4.53 to 28.65)     **0.007**
   Quantile 3           7.11        (−6.19 to 20.40)    0.295       4.83    (−7.95 to 17.61)    0.459
   Quantile 4           22.49       (7.77 to 37.21)     **0.003**   24.36   (10.12 to 38.59)    **0.001**
   Per 1 kg increase    0.73        (0.16 to 1.30)      **0.012**   0.77    (0.22 to 1.32)      **0.006**
  Outer nasal, μm                                                                               
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           13.79       (0.77 to 26.81)     **0.038**   14.83   (2.52 to 27.14)     **0.018**
   Quantile 3           8.24        (−5.55 to 22.03)    0.241       7.26    (−5.79 to 20.30)    0.275
   Quantile 4           13.45       (−1.82 to 28.71)    0.084       16.76   (2.23 to 31.28)     **0.024**
   Per 1 kg increase    0.38        (−0.21 to 0.97)     0.202       0.47    (−0.09 to 1.03)     0.102
  Outer temporal, μm                                                                            
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           14.00       (3.40 to 24.60)     **0.010**   13.19   (2.87 to 23.50)     **0.012**
   Quantile 3           2.00        (−9.23 to 13.22)    0.727       −0.18   (−11.12 to 10.75)   0.974
   Quantile 4           17.94       (5.51 to 30.36)     **0.005**   20.07   (7.90 to 32.24)     **0.001**
   Per 1 kg increase    0.64        (0.16 to 1.12)      **0.009**   0.71    (0.24 to 1.18)      **0.003**
  Inner superior, μm                                                                            
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           8.10        (−5.28 to 21.48)    0.235       8.11    (−4.63 to 20.85)    0.212
   Quantile 3           0.04        (−14.13 to 14.21)   0.996       −2.23   (−15.73 to 11.28)   0.746
   Quantile 4           13.39       (−2.29 to 29.08)    0.094       16.60   (1.56 to 31.64)     **0.031**
   Per 1 kg increase    0.48        (−0.13 to 1.08)     0.122       0.55    (−0.03 to 1.13)     0.062
  Inner inferior, μm                                                                            
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           19.10       (5.49 to 32.72)     **0.006**   19.74   (6.77 to 32.71)     **0.003**
   Quantile 3           8.81        (−5.61 to 23.22)    0.231       7.25    (−6.49 to 20.99)    0.301
   Quantile 4           26.26       (10.30 to 42.22)    **0.001**   29.10   (13.80 to 44.41)    **0.000**
   Per 1 kg increase    0.85        (0.24 to 1.47)      **0.007**   0.92    (0.33 to 1.52)      **0.002**
  Inner nasal, μm                                                                               
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           13.98       (−0.03 to 27.99)    0.051       14.48   (1.29 to 27.67)     **0.031**
   Quantile 3           4.34        (−10.50 to 19.18)   0.566       2.01    (−11.97 to 15.98)   0.778
   Quantile 4           17.43       (1.00 to 33.86)     **0.038**   20.37   (4.80 to 35.94)     **0.010**
   Per 1 kg increase    0.52        (−0.11 to 1.15)     0.107       0.58    (−0.02 to 1.18)     0.058
  Inner temporal, μm                                                                            
   Quantile 1                       1.00 (Ref)                              1.00 (Ref)          
   Quantile 2           15.67       (3.43 to 27.91)     **0.012**   15.97   (4.32 to 27.62)     **0.007**
   Quantile 3           0.55        (−12.41 to 13.51)   0.934       −1.20   (−13.55 to 11.14)   0.848
   Quantile 4           17.77       (3.42 to 32.12)     **0.015**   21.40   (7.65 to 35.15)     **0.002**
   Per 1 kg increase    0.60        (0.04 to 1.15)      **0.034**   0.71    (0.17 to 1.24)      **0.009**

Bold indicates statistically significant.

\*Model 1: adjusted for age and sex.

†Model 2: adjusted for age, gender, axial length, haemoglobin A1c, diabetes duration, use of insulin, height, weight, systolic blood pressure and diastolic blood pressure.

[Table 5](#T5){ref-type="table"} shows the relationship between peripapillary retinal nerve fibre (pRNFL) thickness and grip strength. After adjusting for other factors, the reduced grip strength was significantly associated with lower measurements of average and inferior pRNFL thickness. In addition, the multivariable regression analyses were performed to further adjusting for genotypes of rs2228570 and other factors, and the results were consistent ([online supplementary table 1](#SP1){ref-type="supplementary-material"}).
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Association of grip strength and pRNFL thickness by multivariate linear regression analyses

  pRNFL thickness, μm   Model 1\*   Model 2†                                                   
  --------------------- ----------- ------------------ ------------- ------- ----------------- -------------
  Average                                                                                      
   Quantile 1                       1.00 (Ref)                               1.00 (Ref)        
   Quantile 2           3.83        (1.56 to 6.11)     **0.001**     3.43    (1.21 to 5.66)    **0.003**
   Quantile 3           4.94        (2.54 to 7.34)     **\<0.001**   3.88    (1.53 to 6.23)    **0.001**
   Quantile 4           5.91        (3.25 to 8.56)     **\<0.001**   5.03    (2.42 to 7.64)    **\<0.001**
   Per 1 kg increase    0.22        (0.12 to 0.32)     **\<0.001**   0.18    (0.08 to 0.28)    **\<0.001**
  Superior                                                                                     
   Quantile 1                       1.00 (Ref)                               1.00 (Ref)        
   Quantile 2           −1.61       (−5.28 to 2.06)    0.389         −0.73   (−4.26 to 2.81)   0.687
   Quantile 3           −2.83       (−6.70 to 1.05)    0.152         −3.13   (−6.86 to 0.60)   0.100
   Quantile 4           −0.17       (−4.48 to 4.14)    0.938         −0.18   (−4.35 to 3.99)   0.932
   Per 1 kg increase    0.01        (−0.15 to 0.18)    0.894         0.00    (−0.17 to 0.16)   0.954
  Inferior                                                                                     
   Quantile 1                       1.00 (Ref)                               1.00 (Ref)        
   Quantile 2           8.57        (4.00 to 13.14)    **\<0.001**   7.26    (2.83 to 11.69)   **0.001**
   Quantile 3           12.88       (8.07 to 17.69)    **\<0.001**   10.16   (5.48 to 14.83)   **\<0.001**
   Quantile 4           15.89       (10.58 to 21.20)   **\<0.001**   14.28   (9.09 to 19.46)   **\<0.001**
   Per 1 kg increase    0.59        (0.39 to 0.79)     **\<0.001**   0.51    (0.31 to 0.70)    **\<0.001**
  Nasal                                                                                        
   Quantile 1                       1.00 (Ref)                               1.00 (Ref)        
   Quantile 2           2.56        (−0.42 to 5.53)    0.092         1.23    (−1.74 to 4.19)   0.417
   Quantile 3           2.05        (−1.09 to 5.20)    0.201         0.97    (−2.16 to 4.10)   0.543
   Quantile 4           4.62        (1.07 to 8.16)     **0.011**     3.00    (−0.56 to 6.55)   0.098
   Per 1 kg increase    0.19        (0.06 to 0.33)     **0.005**     0.13    (−0.01 to 0.26)   0.070
  Temporal                                                                                     
   Quantile 1                       1.00 (Ref)                               1.00 (Ref)        
   Quantile 2           0.94        (−2.28 to 4.16)    0.566         1.37    (−1.83 to 4.56)   0.402
   Quantile 3           1.16        (−2.23 to 4.56)    0.501         1.30    (−2.08 to 4.67)   0.452
   Quantile 4           −0.80       (−4.57 to 2.98)    0.680         −0.55   (−4.32 to 3.22)   0.775
   Per 1 kg increase    0.01        (−0.13 to 0.16)    0.887         0.02    (−0.13 to 0.17)   0.788

Bold indicates statistically significant.

\*Model 1: adjusted for age and sex.

†Model 2: adjusted for age, gender, axial length, haemoglobin A1c, diabetes duration, use of insulin, height, weight, systolic blood pressure and diastolic blood pressure.

pRNFL, peripapillary retinal nerve fibre.

Discussion {#s4}
==========

This cross-sectional study reported the association existing between HGS and diabetes, analysing RT and CT. Authors stratified the HGS results in four groups, and all the analyses were conducted explaining the differences between these groups that included a large population aged between 30 and 80 years. Multivariate analysis suggested that lower HGS in patients with diabetes without DR was independently associated with thinner RT and CT.

HGS has been shown to be an indicator of ageing.[@R18] A decrease in HGS associated with ageing correlates with the development of age-related disorders.[@R19] Multiple studies have explored the association between HGS and cardiovascular diseases, cognition and all-cause mortality.[@R5] In addition to age, the results showed that HGS is also associated with gender, height and weight.[@R24] Therefore, these factors were adjusted in the analysis. The thinning of the retina and choroid was also related to ageing, which can seriously affect the visual function in patients, and it can even lead to blindness.[@R25]

The underling mechanism of the associations of reduced HGS with thinner retinal or choroidal layers was elusive. A possible explanation for this may be the common risk factors and pathways between ocular and muscle sarcopenia, such as the blood vessels linking them. The retina and choroid contain a significant number of blood vessels, especially the choroid.[@R26] Their thickness often varies greatly depending on the filling state of the blood vessels. Blood vessels are centres for transporting oxygen and nutrients. Thinning of the retina and choroid indicates a decrease in the density and velocity of blood, thus affecting the delivery of oxygen and nutrients to muscles.[@R27] It leads to a weakening of muscle strength, which is reflected in the decline in a patient's HGS. In addition, patients with diabetes had accelerated ageing process, which leads to loss of muscle strength. The presence and severity of diabetic neuropathy were related to gradual loss of muscle strength and also related to RT and CT. Diabetic nephropathy contributed to loss of muscle strength, and altered RT and CT is a hallmark of renal function in patients with diabetes.

This finding has important implications for the development of methods for earlier diagnosis of diabetic retinal and choroidal changes. Compared with the OCT examination, HGS measurement is easy, simple and inexpensive, which makes it an economically viable method used in the early evaluation of the progress of fundus lesions in patients with diabetes and to monitor their health status.[@R23] Thus, HGS may provide a valuable indicator of retinal status in patients with diabetes. In addition, the present study is the first to identify an association between HGS and RT or CT. It is a new direction for future research on HGS.

This study has some advantages. The subjects covered a wide range of ages, which differs from most previous studies on grip strength that focused on the elderly. The subjects in this study ranged from 30 to 80 years old, with an average age of 64.5±7.7 years. Moreover, the HGS was measured by the dynamometer, which has been recommended as a standard tool for HGS testing by the American Society of Hand Therapy (ASHT) and is considered to be the gold standard for HGS testing. The thickness of the retina and choroid was obtained by the same experienced technician using the latest SS-OCT to ensure that the results are accurate and reliable. However, further study with larger sample sizes is warranted to confirm or refute our findings.

There are several limitations associated with this result. First, this study only measured the HGS and not more sophisticated parameters of muscle quality. However, HGS is a simple and easily administrated measurement in the epidemiologic and community-based study, and HGS has been shown to be an excellent indicator for muscle quality and sarcopenia. Second, investigators have just begun to explore the association of HGS and RT or CT, and more information is needed to gain a better understanding of the connection between them. This study did not explore the long-term impact of HGS changes on RT and CT or track the progress of diabetes and ocular diseases in each patient. Third, all of the patients were Chinese in urban area, thus it is difficult to extend the results to other ethnicities and subjects in rural area. Fourth, the findings may not generalise to types 1 diabetes mellitus and patients with DR. Finally, the vitamin D levels were determined in this study. The associations remain significant after adjusting for polymorphism of vitamin D receptors, indicating that our results were robust and reliable. However, the rs2228570 could not reflect the fluctuations of 25(OH)D, and further studies are warranted to evaluate the relationship between 25(OH)D and OCT parameters.

Conclusion {#s5}
==========

In summary, HGS was significantly associated with RT and CT in this population. Reduced HGS was found to be significantly associated with thinner RT and CT in patients with diabetes without DR, and HGS may provide an easily administered marker of retinal status in patients with diabetes.
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